Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxwell V Meng

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
The Journal of Urology|September 28, 2014
Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancerChristopher J Welty, Janet E Cowan, Hao Nguyen, et al.
The Journal of Urology|October 4, 2016
A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical ProstatectomyHao G Nguyen, Sanoj Punnen, Janet E Cowan, et al.
Cancer|April 25, 2008
Active surveillance for the management of prostate cancer in a contemporary cohortMarc A Dall'Era, Badrinath R Konety, Janet E Cowan, et al.
The Journal of Urology|March 23, 2011
The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancerJared M Whitson, Sima P Porten, Joan F Hilton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Initial Experience with <sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial CancerVadim S Koshkin, Vipul Kumar, Brad Kline, et al.
The Journal of Urology|October 24, 2012
A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancerJames M Burke, Donald L Lamm, Maxwell V Meng, et al.
Kidney Cancer (Clifton, Va.)|November 26, 2019
Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)Timothy W Synold, Melissa Plets, Catherine M Tangen, et al.
Surgical Endoscopy|April 15, 2018
Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for menAhmed A Hussein, Kevin J Sexton, Paul R May, et al.
Nature Immunology|March 17, 2023
Exhausted intratumoral Vδ2<sup>-</sup> γδ T cells in human kidney cancer retain effector functionChiara Rancan, Marcel Arias-Badia, Pranay Dogra, et al.
Cancer Immunology Research|February 19, 2022
Holistic Characterization of Tumor Monocyte-to-Macrophage Differentiation Integrates Distinct Immune Phenotypes in Kidney CancerAdriana M Mujal, Alexis J Combes, Arjun A Rao, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
The Journal of Urology|September 28, 2014
Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancerChristopher J Welty, Janet E Cowan, Hao Nguyen, et al.
The Journal of Urology|October 4, 2016
A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical ProstatectomyHao G Nguyen, Sanoj Punnen, Janet E Cowan, et al.
Cancer|April 25, 2008
Active surveillance for the management of prostate cancer in a contemporary cohortMarc A Dall'Era, Badrinath R Konety, Janet E Cowan, et al.
The Journal of Urology|March 23, 2011
The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancerJared M Whitson, Sima P Porten, Joan F Hilton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Initial Experience with <sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial CancerVadim S Koshkin, Vipul Kumar, Brad Kline, et al.
The Journal of Urology|October 24, 2012
A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancerJames M Burke, Donald L Lamm, Maxwell V Meng, et al.
Kidney Cancer (Clifton, Va.)|November 26, 2019
Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)Timothy W Synold, Melissa Plets, Catherine M Tangen, et al.
Surgical Endoscopy|April 15, 2018
Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for menAhmed A Hussein, Kevin J Sexton, Paul R May, et al.
Nature Immunology|March 17, 2023
Exhausted intratumoral Vδ2<sup>-</sup> γδ T cells in human kidney cancer retain effector functionChiara Rancan, Marcel Arias-Badia, Pranay Dogra, et al.
Cancer Immunology Research|February 19, 2022
Holistic Characterization of Tumor Monocyte-to-Macrophage Differentiation Integrates Distinct Immune Phenotypes in Kidney CancerAdriana M Mujal, Alexis J Combes, Arjun A Rao, et al.
Pageof 19